USANA HEALTH SCIENCES, INC. Share-based Payment Arrangement, Expense, Tax Benefit
USANA HEALTH SCIENCES, INC. (USNA) reported Share-based Payment Arrangement, Expense, Tax Benefit of $2.81 million for the 12-month period ending 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-03-16
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-01-02 was $1.43M, a 6.82% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-10-03 was $857.00K, a 39.80% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-07-04 was $742.00K, a 0.13% decline year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2015-04-04 was $740.00K, a 19.94% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2026 was $2.81M, a 4.23% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $2.69M, a 7.38% increase from fiscal 2023.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $2.51M, a 1.92% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $2.56M, a 9.14% decline from fiscal 2022.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2026-01-03 | $2.81M 10-K · filed 2026-03-16 | |||
| 2024-12-28 | $2.69M 10-K · filed 2026-03-16 | |||
| 2023-12-30 | $2.51M 10-K · filed 2026-03-16 | |||
| 2022-12-31 | $2.56M 10-K · filed 2025-03-12 | |||
| 2022-01-01 | $2.81M 10-K · filed 2024-02-27 | |||
| 2021-01-02 | $2.47M 10-K · filed 2023-02-28 | |||
| 2019-12-28 | $2.73M 10-K · filed 2022-03-01 | |||
| 2018-12-29 | $2.78M 10-K · filed 2021-03-02 | |||
| 2017-12-30 | $5.14M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $5.54M 10-K · filed 2019-02-26 | |||
| 2016-01-02 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.28M derived: sum of 2 quarters · filed 2018-02-28 | $3.02M derived: sum of 3 quarters · filed 2018-02-28 | $3.77M 10-K · filed 2018-02-28 |
| 2015-10-03 | $857.00K 10-Q · filed 2015-11-12 | $1.60M derived: sum of 2 quarters · filed 2015-11-12 | $2.34M 10-Q · filed 2015-11-12 | $3.67M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $742.00K 10-Q · filed 2015-08-12 | $1.48M 10-Q · filed 2015-08-12 | $2.82M derived: sum of 3 quarters · filed 2017-03-01 | $3.43M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $740.00K 10-Q · filed 2015-05-13 | $2.08M derived: sum of 2 quarters · filed 2017-03-01 | $2.69M derived: sum of 3 quarters · filed 2017-03-01 | $3.43M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.95M derived: sum of 2 quarters · filed 2017-03-01 | $2.69M derived: sum of 3 quarters · filed 2017-03-01 | $3.31M 10-K · filed 2017-03-01 |
| 2014-09-27 | $613.00K 10-Q · filed 2015-11-12 | $1.36M derived: sum of 2 quarters · filed 2015-11-12 | $1.97M 10-Q · filed 2015-11-12 | $2.46M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $743.00K 10-Q · filed 2015-08-12 | $1.36M 10-Q · filed 2015-08-12 | $1.85M derived: sum of 3 quarters · filed 2016-03-01 | $2.43M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $617.00K 10-Q · filed 2015-05-13 | $1.10M derived: sum of 2 quarters · filed 2016-03-01 | $1.68M derived: sum of 3 quarters · filed 2016-03-01 | $2.38M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $1.07M derived: sum of 2 quarters · filed 2016-03-01 | $1.76M derived: sum of 3 quarters · filed 2016-03-01 | $2.58M 10-K · filed 2016-03-01 |
| 2013-09-28 | $578.00K 10-Q · filed 2014-11-06 | $1.27M derived: sum of 2 quarters · filed 2014-11-06 | $2.09M 10-Q · filed 2014-11-06 | |
| 2013-06-29 | $697.00K 10-Q · filed 2014-08-05 | $1.51M 10-Q · filed 2014-08-05 | ||
| 2013-03-30 | $812.00K 10-Q · filed 2014-05-07 | |||
| 2012-12-29 | $3.55M 10-K · filed 2015-03-17 | |||
| 2011-12-31 | $3.85M 10-K · filed 2014-03-13 | |||
| 2011-01-01 | $3.99M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |